Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CBT-ENDURE: Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention

NCT04760652 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT04760652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04760652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CBT-ENDURE: Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention
Lead sponsor
Yale University
Phase
Not applicable
Overall status
Completed
Start date
March 5, 2021
Completion date
June 30, 2025
Enrollment
93 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

depression and suicide